KNG1 and COVID-19: This was timely recognized by several groups of investigators early during the pandemic (Roche & Roche, 2020; van de Veerdonk et al., 2020) and most recently was confirmed by a preliminary gene expression analysis study focusing on detailed evaluation of the RAS members, bradykinin and associated systems in samples from COVID‐19 and control patients (Garvin et al., 2020).